Patents matching “formulation”

US 2009169611

Gel-Formulations of Hydrophobic Photosensitizers for Mucosal Applications

ALBRECHT VOLKER [DE] · Granted Jul 2, 2009 · Expires Jun 27, 2029

CA 2702664

FORMULATION PHARMACEUTIQUE A LIBERATION CONTROLEE

ALPHAPHARM PTY LTD [AU] · Granted Apr 23, 2009 · Expires Apr 18, 2029

US 7462603

Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery

The Regents of the University of California · Granted Dec 9, 2008 · Expires Dec 4, 2028

US 7429562

Cyclosporin analog formulations

Isotechnika, Inc. · Granted Sep 30, 2008 · Expires Sep 25, 2028

US 7396542

Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 8, 2008 · Expires Jul 3, 2028

AU 2007332640

Powder formulation for valganciclovir

HOFFMANN LA ROCHE [DE] · Granted Jun 19, 2008 · Expires Jun 14, 2028

US 7368435

Topical endoparasiticide and ectoparasiticide formulations

Summit VetPharm, LLC · Granted May 6, 2008 · Expires May 1, 2028

US 7365165

IL-1 antagonist formulations

REGENERON PHARMACEUTICALS, INC. · Granted Apr 29, 2008 · Expires Apr 24, 2028

US 7357945

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 15, 2008 · Expires Apr 10, 2028

US 7294687

Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 13, 2007 · Expires Nov 8, 2027

CA 2648495

FORMULATIONS A LIBERATION CONTROLEE QUI COMPRENNENT UNE OU PLUSIEURS UNITES DISCRETES NON ENROBEES ET UNE MATRICE A LIBERATION RETARDEE

ALPHAPHARM PTY LTD [AU] · Granted Nov 1, 2007 · Expires Oct 27, 2027

US 7259153

Drug formulation and delivery using crystalline methylated cyclodextrins

Supernus Pharmaceuticals, Inc. · Granted Aug 21, 2007 · Expires Aug 16, 2027

US 7247707

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Jul 24, 2007 · Expires Jul 19, 2027

US 7196074

Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 27, 2007 · Expires Mar 22, 2027

US 7138137

Stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 21, 2006 · Expires Nov 16, 2026

US 7112341

Pulmonary administration of dry powder formulations for treating infertility

Nektar Therapeutics · Granted Sep 26, 2006 · Expires Sep 21, 2026

US 7109323

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 19, 2006 · Expires Sep 14, 2026

US 7087723

Albumin-free factor VIII formulations

UNIVERSITY OF CONNECTICUT · Granted Aug 8, 2006 · Expires Aug 3, 2026

US 2006127471

Pegylated liposomal formulations of hydrophobic photosensitizers for photodynamic therapy

CERAMOPTEC IND INC [DE] · Granted Jun 15, 2006 · Expires Jun 10, 2026

US 7060672

Cyclosporin analog formulations

Isotechnika, Inc. · Granted Jun 13, 2006 · Expires Jun 8, 2026

US 6984402

Chrono delivery formulations and method of treating atrial fibrillation

Elite Laboratories, Inc. · Granted Jan 10, 2006 · Expires Jan 5, 2026

US 6958319

Formulation of boronic acid compounds

The United States of America, as represented by the Department of Health and Human Services · Granted Oct 25, 2005 · Expires Oct 20, 2025

US 6949255

Inhibitory chemical formulation with preservative system

The Board of Regents of the University of Texas · Granted Sep 27, 2005 · Expires Sep 22, 2025

US 6943027

Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery

The Regents of the University of California · Granted Sep 13, 2005 · Expires Sep 8, 2025